See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Francis
NFL
Baseball
Vatican
Motorsports
Real Madrid
Social Media
South America
Tennis
Golf
Catholic Church
Soccer
Published • loading... • Updated

SGLT-2s, GLP-1s, Finerenone Have Unique Benefits in CKD, Diabetes: Meta-Analysis

Summary by ajmc.com
The findings highlight important differences between therapies in managing blood glucose, blood pressure, lipids, and adverse effects in this high-risk patient population.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
ajmc.comajmc.com

SGLT-2s, GLP-1s, Finerenone Have Unique Benefits in CKD, Diabetes: Meta-Analysis

The findings highlight important differences between therapies in managing blood glucose, blood pressure, lipids, and adverse effects in this high-risk patient population.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

ajmc.com broke the news in on Friday, April 25, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Diabetes

Diabetes

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal